Previous 10 | Next 10 |
NeuroBo Pharmaceuticals, Inc. Compliant with All Applicable Nasdaq Listing Criteria PR Newswire BOSTON , Sept. 29, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. ("NeuroBo") (Nasdaq: NRBO) today announced that on September 27, 2022 , NeuroBo recei...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Alextype/Shutterstock.com Traders continue to show interest in short squeeze stocks this week as they seek out likely targets to push higher. This has us checking out Fintel’s Short Squeeze Leaderb...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is rocketing higher on Thursday as investors react to news of a new heart monitor patent . This new patent covers a 12-lead electro...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com NeuroBo (NASDAQ: NRBO ) stock is rising higher on Thursday after the clinical-stage biotechnology company announced a new strategic partnership with Dong-A ST . Neuro...
Boston-based NeuroBo Pharmaceuticals' ( NASDAQ: NRBO ) stock rose ~35% on Sept. 15 after it signed an agreement to license its shareholder Dong-A's two cardiometabolic assets DA-1241 and DA-1726. DA-1241 is being developed to treat nonalcoholic steatohepatitis (NASH)...
NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A's Cardio-Metabolic Therapies PR Newswire Exclusive License Agreement to Develop and Commercialize Phase II Clinical Stage New Chemical Entit...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning! Moving stocks this morning is clinical trial data, propo...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com We’re starting off Wednesday with an overview of the biggest pre-market stock movers and the news moving those shares! That includes earnings reports, reverse stock spli...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Andrus Ciprian / Shutterstock.com NeuroBo Pharmaceuticals (NASDAQ: NRBO ) stock is rocketing higher on Tuesday after the company underwent a reverse stock split this morning. NRBO stock we...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s price action in NeuroBo (NASDAQ: NRBO ) is quite remarkable, to say the least. While many stocks in the market are up today, few have seen triple-digit increases like this clinical-stage biote...
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01 PR Newswire CAMBRIDGE, Mass. , July 30, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transfo...
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...